Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press12510.17650/1994-4098-2012-0-3-4-112-119GYNECOLOGY. DIAGNOSISГИНЕКОЛОГИЯ. ДИАГНОСТИКАPossible pathogenetic types of sporadical ovarian cancerВероятные патогенетические варианты спорадического рака яичниковAshrafyanL. A.АшрафянЛ. А.
Russian Federation
levaa2004@yahoo.comRussian Scientific Center of Rentgenoradiology, Ministry of Health of Russia, MoscowФГБУ «Российский научный центр рентгенорадиологии» Минздрава России, Москва240920123-411211924072014240720142012https://ojrs.abvpress.ru/ojrs/article/view/125

This article in question dwells on a possible pathogenetic model ovarian cancer, it’s histogenesis speciality, the role of ovulation, chronic in- flammation and stem cells. The scheme of two variant of avarian cancer progress and possible ways of prevention it are represented as well.

В статье рассматривается вероятная патогенетическая модель рака яичника, особенности его гистогенеза, роль овуляции, хронического воспаления и стволовых клеток. Представлена схема развития 2 вариантов рака яичников, а также возможные пути профилактики. 

ovarian cancerpathogenesisovulationsuperficial epitheliumheterotopiaschronic inflammationstem cellрак яичниковпатогенезовуляцияповерхностный эпителийгетеротопиихроническое воспалениестволовая клетка1. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;1:18−23.Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. Онкогинекология 2012;1:18−23.2. Глазунов М.Ф. Опухоли яичников. М.: Медгиз, 1954. С. 324.Глазунов М.Ф. Опухоли яичников. М.: Медгиз, 1954. С. 324.3. Auersperg N., Wong A.S., Choi K.C. et al. Ovarian surface epithelium: biology, endocrinology and pathology. Endocr Rev 2001;22:225−8.Auersperg N., Wong A.S., Choi K.C. et al. Ovarian surface epithelium: biology, endocrinology and pathology. Endocr Rev 2001;22:225−8.4. Noara H. Developmental vpatterning in the wrong context: The paradox of epithelial ovarian cancers. Cell Cycle 2005;4:1033−5.Noara H. Developmental vpatterning in the wrong context: The paradox of epithelial ovarian cancers. Cell Cycle 2005;4:1033−5.5. Walthard M.Z. Aetiologieder Ovarialadenoma. Ztschr Geburtsh Gynak 1903;49:233−329.Walthard M.Z. Aetiologieder Ovarialadenoma. Ztschr Geburtsh Gynak 1903;49:233−329.6. Keller Th. L’activite normale et pathologique de l’epithelium germinatif de l’ovaire adalte. Gynecol Et Obstet 1928;17:10−39.Keller Th. L’activite normale et pathologique de l’epithelium germinatif de l’ovaire adalte. Gynecol Et Obstet 1928;17:10−39.7. Максимов А.А. Die hystologishen Vorgange bei der Heilung von Eierstocksverletzungen und die Regenerationsfahigkeit des Eiertockgewebes. Virch Arch 1900; p. 160.Максимов А.А. Die hystologishen Vorgange bei der Heilung von Eierstocksverletzungen und die Regenerationsfahigkeit des Eiertockgewebes. Virch Arch 1900; p. 160.8. Дорохов И.И. Мезотелий париетальной брюшины человека и изменения его при некоторых заболеваниях. Л., 1951.Дорохов И.И. Мезотелий париетальной брюшины человека и изменения его при некоторых заболеваниях. Л., 1951.9. Schiffmann J., Steiner H. Knotchen und Cystchem an der Tube. Zbl Gynak 1926;50:258.Schiffmann J., Steiner H. Knotchen und Cystchem an der Tube. Zbl Gynak 1926;50:258.10. Muller J.H. Les nodules et Kystes paramalpighiennes a la surface de l’ovair, de la tromphe et du ligament large. Ann d’Anat Pathol 1934;11:438−98.Muller J.H. Les nodules et Kystes paramalpighiennes a la surface de l’ovair, de la tromphe et du ligament large. Ann d’Anat Pathol 1934;11:438−98.11. Danforth H. The cytologic relationship of the Walthard cell rest tо the Brenner tumor of the ovary and to the pseudomucinous cystadenoma. Am J Obst Gyn 1942;43:984.Danforth H. The cytologic relationship of the Walthard cell rest tо the Brenner tumor of the ovary and to the pseudomucinous cystadenoma. Am J Obst Gyn 1942;43:984.12. Rubson S.M., Thill L.I. Epithelium-like Inclusions in the heart. Am J Path 1948;3:24.Rubson S.M., Thill L.I. Epithelium-like Inclusions in the heart. Am J Path 1948;3:24.13. Kowalski L.D., Kanbour A.I., Price F.V. et al. A case-matched molecular comparison of extraovar ian versus primary ovarian adenocarcinoma. Cancer 1997;79:1587−94.Kowalski L.D., Kanbour A.I., Price F.V. et al. A case-matched molecular comparison of extraovar ian versus primary ovarian adenocarcinoma. Cancer 1997;79:1587−94.14. Halperin R., Zehavi S., Hadas E. et al. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathol 2001;20:341−5.Halperin R., Zehavi S., Hadas E. et al. Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathol 2001;20:341−5.15. Halperin R., Zehavi S., Langer R. et al. Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 2001;11:403−8.Halperin R., Zehavi S., Langer R. et al. Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 2001;11:403−8.16. Chen L.M., Yamada S.D., Fu Y.S. et al. Molecular similarities between primary peritoneal and primary ovarian carcinomas. Int J Gynecol Cancer 2003;13:749−55.Chen L.M., Yamada S.D., Fu Y.S. et al. Molecular similarities between primary peritoneal and primary ovarian carcinomas. Int J Gynecol Cancer 2003;13:749−55.17. Lacy M.Q., Hartmann L.C., Keeney G.L. et al. C-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer 1995;75:2891−6.Lacy M.Q., Hartmann L.C., Keeney G.L. et al. C-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer 1995;75:2891−6.18. Pere H., Tapper J., Seppala M. et al. Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis. Cancer Res 1998;58:4274−6.Pere H., Tapper J., Seppala M. et al. Genomic alterations in fallopian tube carcinoma: Comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis. Cancer Res 1998;58:4274−6.19. Kindelberger D.W., Lee Y., Miron A. et al. Intraepithelial carcinoma of the fibria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007;31:161−9.Kindelberger D.W., Lee Y., Miron A. et al. Intraepithelial carcinoma of the fibria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007;31:161−9.20. Whittemore A.S., Harris R., Itnyre J. et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US control studies. Am J Epidemiol 1992;136:1212−20.Whittemore A.S., Harris R., Itnyre J. et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US control studies. Am J Epidemiol 1992;136:1212−20.21. Runnenbaum I.B., Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001;123:73−9.Runnenbaum I.B., Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001;123:73−9.22. Cooper G.S., Schildkraut J.M., Whittemore A.S. et al. Pregnensy recency and risk of ovarian cancer. Cancer Caus Contr 1999;10:397−402.Cooper G.S., Schildkraut J.M., Whittemore A.S. et al. Pregnensy recency and risk of ovarian cancer. Cancer Caus Contr 1999;10:397−402.23. NIH Consensus Development Conference Statement. Ovarian cancer: screening, treatment and follow-up. Gynecol Oncol 1994;55:4−14.NIH Consensus Development Conference Statement. Ovarian cancer: screening, treatment and follow-up. Gynecol Oncol 1994;55:4−14.24. Riman T., Persont N.S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol Oxf 1998;49(6):695−707.Riman T., Persont N.S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol Oxf 1998;49(6):695−707.25. Gwinn M.L., Lee N.C., Rhodes P.H. et al. Pregnancy, breast feeding, and oral contra- ceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990;43:559−68.Gwinn M.L., Lee N.C., Rhodes P.H. et al. Pregnancy, breast feeding, and oral contra- ceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990;43:559−68.26. Nanca P.C., Greenwald P., Chorost S. et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984;119:705−13.Nanca P.C., Greenwald P., Chorost S. et al. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984;119:705−13.27. Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study 1968−2004. Br J Cancer 2006;95(3):385−9.Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study 1968−2004. Br J Cancer 2006;95(3):385−9.28. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774−86.Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774−86.29. Brinton L.A., Lamb E.J., Moghissi K.S. et al. Ovarian cancer risk after the use of ovulation stimulating drugs. Obstet Gynecol 2004;103:1194−203.Brinton L.A., Lamb E.J., Moghissi K.S. et al. Ovarian cancer risk after the use of ovulation stimulating drugs. Obstet Gynecol 2004;103:1194−203.30. Ness R.B., Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459−67.Ness R.B., Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459−67.31. Wang J., Luo F., Lu J.J. et al. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. Int J Cancer 2002;97:163−7.Wang J., Luo F., Lu J.J. et al. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. Int J Cancer 2002;97:163−7.32. Schiffenbauer Y.S., Meir G., Maoz M. et al. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin. Gynecol Oncol 2002;84:296−302.Schiffenbauer Y.S., Meir G., Maoz M. et al. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin. Gynecol Oncol 2002;84:296−302.33. Rosenberg L., Palmer J.R., Zauber A.G. et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654−61.Rosenberg L., Palmer J.R., Zauber A.G. et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654−61.34. Purdie D.M., Bain C.J., Siskind V. Hormon replacement therapy and the risk of epithelial ovarian cancer. Br J Cancer 1999; 81:559−64.Purdie D.M., Bain C.J., Siskind V. Hormon replacement therapy and the risk of epithelial ovarian cancer. Br J Cancer 1999; 81:559−64.35. Gaspard U.J. Romus M.A., Gillain D. et al. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception 1983;27:577−90.Gaspard U.J. Romus M.A., Gillain D. et al. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Contraception 1983;27:577−90.36. McNatty K.P., Smith D.M., Makris A. et al. The microenvironment of the human antral follicle: Inter- relationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979;49:851−60.McNatty K.P., Smith D.M., Makris A. et al. The microenvironment of the human antral follicle: Inter- relationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 1979;49:851−60.37. Tashiro H., Katabuchi H., Begum M. et al. Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and independent growth in human ovarian surface epithelial cell lines. Cancer Sci 2003;94:953−9.Tashiro H., Katabuchi H., Begum M. et al. Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and independent growth in human ovarian surface epithelial cell lines. Cancer Sci 2003;94:953−9.38. Ji Q., Liu P.I., Chen P.K. et al. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Int J Cancer 2004;112:803−914.Ji Q., Liu P.I., Chen P.K. et al. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Int J Cancer 2004;112:803−914.39. Seeger H., Wallwiener D., Mueck A.O. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? Eur J Gynaecol Oncol 2006;27:139−41.Seeger H., Wallwiener D., Mueck A.O. Is there a protective role of progestogens on the proliferation of human ovarian cancer cells in the presence of growth factors? Eur J Gynaecol Oncol 2006;27:139−41.40. Edmondson R.J., Monaghan J.M., Davies B.R. The human ovarian surface epithelium is an androgen responsive tissue. Br J Cancer 2002;86:879−85.Edmondson R.J., Monaghan J.M., Davies B.R. The human ovarian surface epithelium is an androgen responsive tissue. Br J Cancer 2002;86:879−85.41. Altinoz M.A, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxyge-naseinhibitions as likely mechanisms behind the acеtaminophen – and NSAID-prevention of the ovarian cancer. Neoplasma 2004;51:239−47.Altinoz M.A, Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxyge-naseinhibitions as likely mechanisms behind the acеtaminophen – and NSAID-prevention of the ovarian cancer. Neoplasma 2004;51:239−47.42. Albini A., Tosseti F., Benelli R., Noonan D. Tumor inflammatory angiogenesis and its chemoprevation. Cancer Res 2005;65(23):10637−41.Albini A., Tosseti F., Benelli R., Noonan D. Tumor inflammatory angiogenesis and its chemoprevation. Cancer Res 2005;65(23):10637−41.43. Stecca B., Mas C., Altaba A. Interference with HH-GLI signaling inhibits cancer. Trends Mol Med 2005;11(5):199−203.Stecca B., Mas C., Altaba A. Interference with HH-GLI signaling inhibits cancer. Trends Mol Med 2005;11(5):199−203.44. Shafer Z.T., Brugge J.S. IL-6 involvement in epitalial cancer. J Clin Invest 2004;117(12):3660−3.Shafer Z.T., Brugge J.S. IL-6 involvement in epitalial cancer. J Clin Invest 2004;117(12):3660−3.